Pulse Biosciences Inc PLSE
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if PLSE is a good fit for your portfolio.
News
-
Pulse Biosciences Reports Business Updates and Fourth Quarter & Full Year 2023 Financial Results
-
Pulse Biosciences Announces Plans to Initiate a Rights Offering
-
Pulse Biosciences Schedules Fourth Quarter & Full Year 2023 Financial Results Conference Call for March 28, 2024
-
Pulse Biosciences Announces FDA 510(k) Clearance for its CellFX® nsPFA™ Percutaneous Electrode System
-
Pulse Biosciences Announces Positive 60-Day Follow-Up Evaluations for Initial Patients treated in the CellFX® nsPFA™ 360° Cardiac Catheter First-in-Human Feasibility Study
-
Pulse Biosciences Announces Preliminary Findings from its CellFX nsPFA 360 Cardiac Catheter First-In-Human Feasibility Study to be Featured in Podium Presentation at the AF Symposium
-
Pulse Biosciences Files 510(k) Submission with U.S. FDA for its CellFX® nsPFA™ Cardiac Clamp
-
Pulse Biosciences Up 16% on Product Updates, Potential Stock Purchases by Duggan
Trading Information
- Previous Close Price
- $8.40
- Day Range
- $8.57–9.09
- 52-Week Range
- $2.36–13.62
- Bid/Ask
- $7.68 / $7.79
- Market Cap
- $479.75 Mil
- Volume/Avg
- 310,476 / 178,890
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- < 0.01%
Company Profile
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled. Substantial revenue is generated from North America Majorly due to the sale of systems.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Stock Style Box
- Small Growth
- Total Number of Employees
- 61
- Website
- https://www.pulsebiosciences.com
Comparables
Valuation
Metric
|
PLSE
|
SWAV
|
ATEC
|
---|---|---|---|
Price/Earnings (Normalized) | — | 83.78 | — |
Price/Book Value | 9.19 | 18.01 | 24.53 |
Price/Sales | — | 17.04 | 3.46 |
Price/Cash Flow | — | 51.86 | — |
Price/Earnings
PLSE
SWAV
ATEC
Financial Strength
Metric
|
PLSE
|
SWAV
|
ATEC
|
---|---|---|---|
Quick Ratio | 9.28 | 10.61 | 1.86 |
Current Ratio | 9.50 | 11.76 | 2.86 |
Interest Coverage | — | 26.24 | −10.23 |
Quick Ratio
PLSE
SWAV
ATEC
Profitability
Metric
|
PLSE
|
SWAV
|
ATEC
|
---|---|---|---|
Return on Assets (Normalized) | −44.65% | 19.87% | −9.89% |
Return on Equity (Normalized) | −158.65% | 35.18% | — |
Return on Invested Capital (Normalized) | −48.20% | 22.54% | −9.94% |
Return on Assets
PLSE
SWAV
ATEC
Medical Instruments & Supplies Industry Comparables
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
---|---|---|---|---|---|
ISRG
| Intuitive Surgical Inc | Jrnwfqsgw | Dmbw | $141.5 Bil | |
BDX
| Becton Dickinson & Co | Jvtysbky | Lqbywb | $71.5 Bil | |
ALC
| Alcon Inc | Rbxhhkdp | Ywylg | $40.7 Bil | |
CLPBY
| Coloplast A/S ADR | Nsjgdsctl | Ppqn | $30.4 Bil | |
RMD
| ResMed Inc | Vpmdwdjsbl | Swnbcb | $29.1 Bil | |
WST
| West Pharmaceutical Services Inc | Qstgbsttbm | Mxm | $29.0 Bil | |
BAX
| Baxter International Inc | Xyxvmyqx | Rxydkys | $21.8 Bil | |
COO
| The Cooper Companies Inc | Bvxfdwfd | Rpcqkg | $20.2 Bil | |
HOLX
| Hologic Inc | Qrbmtmbq | Fcwkmx | $18.3 Bil | |
TFX
| Teleflex Inc | Vxwl | Cmd | $10.6 Bil |